Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEDIPASVIR\SOFOSBUVIR vs LENALIDOMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEDIPASVIR\SOFOSBUVIR vs LENALIDOMIDE: Safety Overview

Metric LEDIPASVIR\SOFOSBUVIR LENALIDOMIDE
Total FAERS Reports 23,616 349,955
Deaths Reported 1,371 35,942
Death Rate 5.8% 10.3%
Hospitalizations 4,031 86,495
Average Patient Age 57.9 yrs 69.9 yrs
% Female Patients 42.9% 50.0%
FDA Approval Date N/A Aug 3, 2023
Manufacturer N/A Padagis US LLC
Route N/A ORAL
Marketing Status N/A Prescription